Anders Lideståhl | Karolinska Institutet

Stäng

Ett medicinskt universitet

Sök

Meny

Ett medicinskt universitet

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: CANCERS. 2023;15(24):5736

Dosimetric Comparison of Conventional Radiotherapy, Volumetric Modulated Arc Therapy, and Proton Beam Therapy for Palliation of Thoracic Spine Metastases Secondary to Breast or Prostate Cancer

Lidestahl A; Freden E; Siegbahn A; Johansson G; Lind PA; Ishikawa E; Matschke J; Rueckert M; Deloch L
Article: CANCERS. 2021;13(20):5153

Estimated Risk of Radiation-Induced Cancer after Thymoma Treatments with Proton- or X-ray Beams

Lidestahl A; Johansson G; Siegbahn A; Lind PA
Article: PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS. 2019;60:120-126

An in silico planning study comparing doses and estimated risk of toxicity in 3D-CRT, IMRT and proton beam therapy of patients with thymic tumours

Lidestahl A; Mondlane G; Gubanski M; Lind PA; Siegbahn A
Article: ACTA ONCOLOGICA. 2007;46(2):187-193

Quantitative assessment of lung density changes after 3-D radiotherapy for breast cancer

Blom-Goldman U; Svane G; Wennberg B; Lidestahl A; Lind PARM

Alla övriga publikationer

Thesis / dissertation: 2024

Radiation-induced toxicity and secondary malignant neoplasms in radiotherapy of intrathoracic tumors

Lideståhl, Anders
Published conference paper: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006;64(3):765-770

ROC curves and evaluation of radiation-induced pulmonary toxicity in breast cancer

Lind PA; Wennberg B; Gagliardi G; Rosfors S; Blom-Goldman U; Lideståhl A; Svane G
Letter: ACTA ONCOLOGICA. 2006;45(2):210-212

Reassessment for radical surgery after palliative chemotherapy in locally advanced pancreatic carcinoma:: Two case-reports

Lideståhl A; Permert J; Linder S; Bylund H; Edsborg N; Lind P
Review: ACTA ONCOLOGICA. 2006;45(2):136-143

Efficacy of systemic therapy in advanced pancreatic carcinoma

Lideståhl A; Permert J; Linder S; Bylund H; Edsborg N; Lind P
Published conference paper: ACTA ONCOLOGICA. 2005;44(3):236-239

Capecitabine as third line therapy in patients with advanced colorectal cancer

Gubanski M; Naucler G; Almerud A; Lideståhl A; Lind PARM

Anställningar

Anknuten till Forskning, Onkologi-Patologi, Karolinska Institutet, 2023-2026

Examina och utbildning

Medicine Doktorsexamen, Institutionen för onkologi-patologi, Karolinska Institutet, 2024

Nyheter från KI

Kalenderhändelser från KI